INTRODUCTION
A large body of evidence suggests that socioeconomic position (SEP) is an important determinant of cardiovascular and metabolic health. 1 2 Lower childhood and adult SEP are associated with a higher risk of type 2 diabetes and cardiovascular disease (CVD), partly through chronic inflammation, which is associated with chronic stress. 3 People who experience social deprivation are thought to be subject to environmental, psychological and behavioural stressors, which eventually wear and tear the neuroendocrine, nervous and immunological systems, a process that is known as allostasis and is associated with an increased risk of chronic disease. 4 5 Systematic changes in SEP across the lifespan, which are best described by the term social mobility, are also associated with subsequent risk of chronic disease. People in upward social mobility, that is, having higher SEP in later stages of the life course compared with earlier stages have decreased risk of various detrimental effects on health, such as psychiatric disorders, 6 7 insulin resistance, 8 type 2 diabetes, 3 9 cardiovascular mortality 10 and allcause mortality 11 compared with those in downward social mobility.
Although downward social mobility is associated with an increased risk of various chronic diseases, 9 11 12 its link with subclinical form of disease, which is very important in terms of disease prevention, remains underinvestigated. Inflammatory and metabolic markers, such as C reactive protein (CRP), fibrinogen, glycated haemoglobin (HbA1c) and highdensity lipoprotein (HDL) cholesterol are implicated in pathogenic processes 13 and widely used as predictors of cardiovascular and metabolic health.
14 Their association with social mobility, however, remains poorly understood. To the best of our knowledge, scarce evidence suggests that downward social mobility is associated with increased levels of inflammatory markers, such as CRP and fibrinogen, 3 15 and decreased levels of metabolic markers, such as HDL, 8 while the association with HbA1c has yet to be explored.
Our study aims to examine the associations between changes in SEP over the life course and inflammatory and metabolic markers in older adults and add to the current knowledge of how social mobility might be associated with pathological processes and subclinical form of disease, with a particular interest in the role of later life SEP and upward social mobility in reversing the harmful effects of social disadvantage in childhood on later life inflammatory and metabolic profiles of older adults.
METHODS

Data source and study populations
The English Longitudinal Study of Ageing (ELSA) is a prospective observational study of community-dwelling people aged 50 years or older. It began in 2002-2003 (wave 1) with a core sample of 11 391 participants who had earlier participated in Health Survey for England (HSE) in 1998, 1999 and 2001 and were selected by using a multistage stratified random probability design. After the baseline, follow-up interviews and health examinations, including blood sample collections, took place at regular 2-year and 4-year intervals, respectively.
The National Research and Ethics Committee approved ELSA, while informed consent has been obtained from all participants. More information on ELSA can be found at http://www. elsa-project.ac.uk/.
Our study uses data from ELSA wave 2 (2004-2005) . ELSA wave 2 had two components: the first follow-up interview and the first (baseline) health examination survey. Out of the 11 391 participants, 8780 took part in the follow-up interview of which 7666 participated in the health examination. Among those who participated in the health examination, 6652 were eligible for blood sample collection (ie, did not have a history of fits or convulsion, bleeding or clotting disorders and have never been prescribed anticoagulants) and consented to give blood sample. Our analytic sample comprised 6142 participants (more details on the exclusion criteria are presented in figure 1 ). To gain a better understanding of the non-response and its potential implications for our findings, we conducted an analysis of non-response, which is presented in online supplementary table S1.
Measurements
Assessment of social mobility
Childhood SEP was measured using father's or main carer's occupation when participants were 14 years old. Participants whose fathers worked in managerial, professional, administrative, trade-related and services-related occupations or were business owners were assigned to the high childhood SEP category, whereas low childhood SEP was assigned for those whose fathers had manual or casual occupations or those whose fathers were unemployed, sick or disabled. Participants whose fathers were in the armed forces or retired when they were 14 years old (n=222), and those whose information about paternal occupation was missing (n=32) were excluded from analyses as their childhood SEP could not be classified.
Adult SEP was measured using data from the last main job of participants, which then was dichotomised into low and high occupational class according to the National Statistics Socioeconomic Classification (NS-SEC) scheme. Participants in managerial, professional or intermediate occupations were assigned to high adult SEP, while those who worked in routine, manual or semimanual occupations were assigned to low adult SEP. The small numbers of participants who had never worked (n=86) or were of unknown occupation (n=2) were excluded from analyses because they could be classified in any of the existing categories. We then combined dichotomous childhood SEP and adult SEP to derive a social mobility variable with the following four categories: stable high SEP (high childhood and adult SEP), downward social mobility (high childhood SEP, but low adult SEP), upward social mobility (low childhood SEP, but high adult SEP) and stable low SEP (low childhood and adult SEP).
Inflammatory and metabolic markers
CRP, fibrinogen, HbA1c and HDL were measured from blood samples collected by nurses at participants' homes during the ELSA wave 2 health examination survey. More information on the measurement of these markers can be obtained from the HSE 2004 technical report (http://www.hscic.gov.uk/catalogue/ PUB01170/hea-surv-ethn-min-eng-2004-rep-v2.pdf ) as both ELSA and HSE used the same protocols and infrastructure to analyse the blood samples. We log-transformed these four markers as they were positively skewed. To provide more clinically meaningful information, HbA1c and HDL levels were in addition categorised into binary variables based on clinical cut-off. For HbA1c, the levels of ≤5.6% were grouped as normal, while those between 5.7% and 6.4% were grouped as prediabetes as per American Diabetes Association recommendation. Since the study of diabetes was outside the scope of this work, we excluded participants whose HbA1c≥6.5%, which is a criterion for the clinical diagnosis of type 2 diabetes. 16 Regarding HDL, we dichotomised it by assigning men with HDL levels <1 mmol/L (40 mg/dL) and women with HDL levels <1.3 mmol/L (50 mg/dL) in the suboptimal HDL group. 17 
Covariates
Based on previous evidence, we used age, age squared, sex and baseline (ie, ELSA wave 2) cardiovascular (ie, hypertension, angina, heart attack, congestive heart failure, heart murmur, abnormal heart rhythm and stroke) and non-CVDs (ie, chronic lung disease, asthma, arthritis, osteoporosis, cancer excluding minor skin cancers, Parkinson's disease, emotional/nervous/psychiatric problems, Alzheimer's disease, and dementia or other serious memory impairment) as potential confounders of the examined association, 15 18 and elevated depressive symptoms (≥4 symptoms on the eight-item Center for Epidemiologic Studies Depression Scale (CES-D)), 18 smoking (current smoker, ex-smoker and never a smoker), 19 physical activity ( physical inactivity, low-intensity, moderate-intensity and vigorous-intensity physical activity at least once a week) 20 21 and frequency of alcohol consumption (daily or almost daily, 1-2 times a week, 1-2 times a month, never or almost never) 22 as potential mediators of it. 15 23 We also adjusted our models for the following anthropometric measures: body mass index (BMI), waist circumference (WC) and waist-to-hip ratio (WHR), which had also been measured during the wave 2 health examination. 24 and categorised using established cut-points. 25 26 We included in the analysis different anthropometric measures, as each one of them may confer uniquely to CVD risk and be differential associated with social mobility. 26 To avoid unnecessary exclusions because of missing values in the following covariates: BMI, WC, WHR, alcohol consumption and depressive symptoms, we applied the missing-indicator technique and added a category for missing values in all these variables.
Statistical analysis
We analysed the sample characteristics according to social mobility categories and estimated multivariable linear and logistic regression models of the association between social mobility and the four markers. We adjusted our models for age, age squared and sex, then for prevalent CVD and non-CVD, and finally, for health behaviours, including obesity, alcohol consumption, smoking, physical activity and elevated depressive symptoms. We reported the pooled sample as we did not find any significant sex interaction. The analyses were conducted using STATA V.12 (StataCorp LP). Table 1 presents the characteristics of the sample. Compared with participants with stable high SEP or upwardly mobile, those in stable low SEP and downward social mobility were more likely to be older, obese, physically inactive, smokers and depressed. They also had more comorbidities and consumed alcohol less frequently. Table 2 shows the overall distribution of inflammatory and metabolic markers. CRP, fibrinogen and HbA1c levels were the highest (worse) among those in stable low SEP. Participants who were downwardly mobile had the second highest levels of the markers and were followed by those who were in upward social mobility trajectory. Those in stable high SEP had the lowest (best) levels in all these biomarkers. HDL levels were the highest (best) among people with stable high SEP and the lowest (worst) among those with stable low group. Proportion of prediabetes was the highest among those experiencing downward social mobility, but was the lowest among those in stable high SEP. In contrast, proportion of having suboptimal HDL levels was the highest among those with stable high group but was the lowest among those with stable low group. Table 3 presents the linear regression models. We found that CRP levels were the highest among participants in stable low SEP (1.348 mg/L, 95% CI 1.259 to 1.45), followed by those who experienced downward social mobility (1.247 mg/L, 95% CI 1.169 to 1.331), and then those who experienced upward social mobility (1.135 mg/L, 95% CI 1.054 to 1.221), compared with people in stable high SEP. We also found a similar pattern of the association between social mobility and fibrinogen. Participants in upward social mobility did not differ significantly in terms of their HbA1c levels from those in stable high SEP, whereas those in downward trajectory or those in stable low SEP had significantly higher levels of HbA1c. The association between social mobility and HDL followed a slightly different pattern showing that participants experiencing downward social mobility had slightly higher HDL levels than those experiencing upward social mobility. The statistical controlling for health behaviours, obesity and elevated depressive symptoms, fully explained the associations with fibrinogen and HbA1c, but only partially those with CRP and HDL.
RESULTS
Interestingly, after adjusting for all covariates, CRP levels of those in upward social mobility were not significantly different from those in stable high SEP, while the CRP levels of participants in downward drift or stable low SEP remained significantly higher. Table 4 shows the results from logistic models. We found that the risk of prediabetes among participants in upward SEP did not significantly differ from the risk of participants in stable SEP (OR 1.14, 95% CI 0.9 to 1.38). However, those downwardly mobile showed an increased risk of prediabetes by 25%, compared with those in stable high SEP independent of age, sex and chronic conditions. The risk of having suboptimal HDL levels among those in upward, downward or stable low SEP were significantly higher than that among those in stable high SEP regardless of age, sex and chronic conditions. Nevertheless, the strength of these associations was attenuated after accounting for health behaviours. N (%) unless specified elsewhere. HDL cholesterol: optimal levels ≥1.0 mmol/L (men) or ≥1.3 mmol/L (women); suboptimal levels <1.0 mmol/L (men) or <1.3 mmol/L (women). *One-way ANOVA and χ 2 for continuous and categorical variables, respectively, and p value did not take into account the effect of missing group. †Also included participants who were excluded from analyses due to having CRP>8 mg/l. ‡Also included participants who were excluded from analyses due to being diagnosed with type 2 diabetes or having HbA1c≥6.5%. ANOVA, analysis of variance; CRP, C reactive protein; HbA1c, glycated haemoglobin; HDL, high-density lipoprotein. 
DISCUSSION
Our findings suggest that there are associations between social mobility and inflammatory (ie, CRP and fibrinogen) and metabolic markers (ie, HbA1c and HDL) with the association between social mobility and CRP persisting after adjustment for covariates. Participants in stable high SEP or upward social mobility had more favourable inflammatory and metabolic profiles characterised by lower levels of CRP, fibrinogen and HbA1c, compared with those in stable low SEP or downward social mobility. However, they had lower HDL levels, compared with those who had stable high SEP or experienced downward social mobility. The results from linear and logistic regression models are consistent. Adjustments for health behaviours, obesity and elevated depressive symptoms fully explained the associations between social mobility and fibrinogen and HbA1c, but partially explained the association with CRP and HDL.
Methodological considerations
Our study is among the first to investigate the associations between social mobility and inflammatory and metabolic markers, and provide insight into the dynamic association between SEP and subclinical disease markers over the life course. An obvious strength of our study is the use of a large national community-dwelling sample and rich observational data from ELSA, which is a well-established survey. The first made our findings more applicable and generalisable to older adults, and the latter allows for a fuller exploration of the role of potential confounders and mediators. Our study also had several limitations, which need to be considered when interpreting our findings. First, childhood SEP has been measured retrospectively and thus might be susceptible to recall bias. Nevertheless, this measure of childhood SEP appears to have good predictive validity as it has been successfully used to predict the incidence of disease 18 and mortality. 27 Second, it is uncertain whether the results can be generalised to younger generations, especially given changes to the structure of the labour market in the past 50 years. Our online supplementary analysis found significant differences between respondents and non-respondents on a number of characteristics. To an extent our study has been affected by attrition and non-response bias and our analytical sample might not fully represent the original ELSA sample making our findings a rather conservative account of the true associations between social mobility and inflammatory and metabolic biomarkers. Third, we could not account for important mediating factors, such as diet and medication usage, particularly 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins). 25 Our social mobility variable did not encapsulate information on early adult SEP, that is, education and thus is an imperfect indicator of social mobility. It also did not capture SEP at a household or a state level, which were also reported to be associated with inflammatory markers. 28 29 In addition, due to the lack of appropriately prospective data, we could not establish the temporality of events and draw causal conclusions about the role of covariates such as unhealthy behaviours in the observed association. With regard to the missing-indicator technique used in dealing with missing covariates, the benefit outweighs the impact on distorting the results as only small proportion of data (<10%) was missing.
Comparison of our findings with other studies
In accordance with previous studies, 3 15 we found that participants in stable low SEP group had the highest CRP levels, followed those in downward social mobility trajectory and those in the upward social mobility, while those with stable high SEP had the best (lowest) CRP levels. These findings are also consistent with those of an earlier study suggesting that the association between adulthood SEP is associated with CRP levels independent of childhood SEP. 23 Our fibrinogen findings concur with those by Ploubidis et al, 30 who reported negative associations between both childhood and adult SEP and fibrinogen levels in older adults. Nevertheless, previous evidence failed to find an association between social mobility and fibrinogen levels. 15 Unlike Lawlor et al, 8 who found that in comparison with participants in stable high SEP only those who experienced low SEP throughout their life had significantly increased risk of low HDL, we found that those in upward and downward social mobility also had an increased risk of suboptimal HDL levels. The discrepancy between our findings and theirs possibly can be attributed to sample differences; Lawlor et al used a sample of women aged 60-79 years, whereas we used as a sample that comprised men and women aged 50 years or older.
Implication of our findings
Our study highlights the importance of changes in SEP for metabolic and inflammatory markers. The implications of our findings are considerable. First, the association between social mobility and CRP indicates that adult SEP is important for chronic inflammation, independent of childhood SEP and likely can partially mitigate the effect of experiences of social disadvantage in childhood on it. The lack of any difference in HbA1c levels between participants in stable high SEP and those in upward social mobility groups further strengthens our argument about the role of upward social mobility as a factor that ameliorates the effect of social disadvantage in childhood. However, the findings that people who started off better but later experienced downward social mobility have better HDL levels compared with those in an upward trajectory suggest the importance of childhood SEP for HDL, irrespective of adult SEP.
In accordance with previous evidence, 18 our findings also suggest that social mobility is associated with the inflammatory and metabolic profiles of older people through unhealthy behaviours, obesity and depression. Regarding physical activity role in the examined associations, evidence suggests that people in stable high SEP and those in upward social mobility were likely to increase their levels of physical activity and physical fitness when they became adults, 20 while increased physical activity was found to be associated with reduced levels of CRP 31 and blood sugar, 32 but increased HDL levels. 33 Downward social mobility has also been associated with poorer self-reported mental health in men 34 and depression independent of childhood or adult SEP, 6 while associations between elevated depressive symptoms and increased CRP levels have also been demonstrated. 35 Further, downward social trajectory is associated with obesity, 36 which in turn is associated with increased CRP 31 and blood sugar levels 32 but decreased HDL levels. 33 One study also suggested that the upward social trajectory could protect women but not men from having high-risk adiposity profiles. 37 Downward family income trajectory is also associated with increased tobacco and alcohol use in adolescence, 19 which are associated with increased CRP 31 and fibrinogen levels 38 but decreased HDL levels. 33 The risk of unfavourable alcohol drinking in men was also found to be increased in a group of downward social mobility. 22 The potential mechanisms that health behaviours might interplay with social mobility are described in more detail in online supplementary material.
CONCLUSION
Social mobility is associated with inflammatory and metabolic markers in older adults with some associations persisting after full adjustment for covariates. Compared with participants in stable high SEP or upward social trajectory, those who were in stable low SEP or experienced downward social mobility were more likely to have elevated levels of CRP, fibrinogen and HbA1c. Participants who experienced upward, downward or stable low SEP tend to have lower HDL levels with no discernible patterns, compared with those who remained in high SEP throughout their lives. Health behaviours explain some of these associations. Upward social mobility seems to be associated with a partial reversal of the effect of social disadvantage in childhood on older adults' inflammatory profile.
What is already known on this subject
Childhood and adult socioeconomic position (SEP) are associated with inflammatory and metabolic markers, which are excellent predictors of cardiovascular disease, at older ages.
What this study adds ▸ Systematic changes in SEP across the lifespan, which are best described by the term social mobility, are also associated with inflammatory and metabolic markers at older ages. ▸ Participants in stable high SEP or upward social mobility were more likely to have a healthier biomarker profiles, that is, lower C reactive protein, fibrinogen and glycated haemoglobin, compared with those in stable low SEP or downward social mobility trajectory. ▸ Health behaviours, obesity and depressive symptoms provided a partial explanation of the associations between social mobility and these markers. ▸ Adult SEP is important for chronic inflammation, independent of childhood SEP, and likely can partially mitigate and reverse life time inflammation-related and metabolism-related pathogenic processes that are associated with experiences of social disadvantage in childhood.
